alpha labs retatrutide – 24mg – Prime Lab Peptides Retatrutide 10mg Research Peptide (GLP-1/GIP/Glucagon

While availability and regulatory approval are still evolving, certain groupsincluding individuals with obesity, insulin resistance, PCOS, metabolic syndrome, or previous weight loss challengesmay eventually become ideal candidates for this advanced therapy

The diabetes rate has also remained flat for the past few years, according to Gallup's data

To contextualise that number: the landmark STEP 1 trial of semaglutide 2.4 mg showed a mean weight loss of approximately 14.9%, and the SURMOUNT-1 trial of tirzepatide reached 20.9% at its highest dose [2, 3]

The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis